Navigation Links
State of the Health & Wellness Category: 2010
Date:3/13/2010

unique dietary supplement that works in concert with XanGo Juice to address key components of everyday health. Product formulator and American Institute of Stress Fellow, Dr. Shawn Talbott, reports that study participants who consume both XanGo Juice and Eleviv in synergy have greater improvement of metabolic balance, decreased tension and lower levels of the inflammation marker CRP than those who consumed Eleviv alone. Additionally, those who took the two products together reported increased vigor levels in half the time of those using only one of the products.

Eleviv: Scientifically Tested to Improve Your Vigor

The quest for improved vigor – a scientific term for physical energy, mental acuity and emotional well-being – represents a growing consumer segment of $80 billion annually in the U.S. Artificial stimulants, sugar-packed and caffeine-heavy drinks, and sleep aids flood the market, but only address one component of the vigor equation and are often accompanied by sharp peaks and punishing crashes. In contrast, Eleviv addresses the root of the problem – metabolic imbalance – and works naturally within the body to restore proper balance and help people feel great again, in a sustainable way.

The launch of Eleviv hits the market after years of scientific research and discovery. Dr. Talbott explains, “When the body is out of balance, people are likely to suffer reduced energy, depressed mood, reduced mental acuity, poor coping with stress and even stored body fat. As a scientist, I ask, how can we use modern technology to enhance delivery of scientific properties found in nature to restore the body’s balance?”
In several pre-market clinical trials, Eleviv has shown the ability to reduce tension and improve vigor by significantly increasing metabolic balance. Elevi
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
8. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
9. Red wine compound shown to prevent prostate cancer
10. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
11. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
State of the Health & Wellness Category: 2010 
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... finalist in 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright Bulb ... for B2B brands. BESLER Consulting's campaign for the launch of their Readmissions Analytics ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today welcomed ... accepted for review OPKO’s New Drug Application for a new treatment for chronic ...
(Date:8/3/2015)... ... ... The art of preparing and cooking food comes naturally to some. For ... Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that she is skilled ... Kitchen with the world. , Since Americans tend to be undereducated about Persian cuisine, ...
(Date:8/3/2015)... ... ... The U.S. Food and Drug Administration (FDA) recently approved a new non-invasive treatment ... naturally in the body and helps absorb and breakdown fat cells. Previously, plastic surgery ... are invasive procedures and very expensive for most people. Now with Kybella, there is ...
(Date:8/3/2015)... ... ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility Medical Director ... August. The new facility is licensed under Dignity Health Arizona General Hospital ... is an excellent leader and will ensure our new freestanding emergency room delivers the ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3
... Children With Food,Allergies, FAIRFAX, Va., Feb. 11 ... announce the release of two animated,DVDs that both entertain ... Couldn,t Eat Peanuts ... Goes to School and,Alexander, the ... help,children cope with their own allergies and teach other ...
... Corporation,(NYSE: CSK ), a leading international manufacturer ... of printed pharmaceutical,leaflets in North America, today announced ... Long Island, N.Y., and relocating,from its current location ... business has grown substantially since we moved to ...
... from seven countries, including teams of robotics and brain ... been set up with the aim of imitating nature. ... in the animal kingdom, the multinational team is developing ... whiskered robot will be able to quickly locate, identify ...
... the American Academy ... of Dermatology, ... indicates the 8-oxo-guanine DNA glycosylase (OGG1),encapsulated in liposomes is an effective ... and increasing,collagen production in UV irradiated skin cells. The data was ...
... 11 /PRNewswire-FirstCall/ - Neurochem Inc. (NASDAQ:,NRMX; TSX: NRM) ... Dr.,Francesco Bellini, Neurochem,s Chairman, President and Chief Executive,Officer, ... the new,nutraceutical business, will present Neurochem,s strategy at ... held at the Waldorf-Astoria, in New York,(NY). The ...
... Complex fibroadenomas have a low incidence of malignancy, so ... and avoid surgical biopsy, according to a new study ... Medical Center in Jerusalem. , A fibroadenoma is a ... young women. They are not usually associated with breast ...
Cached Medicine News:Health News:New Alexander, the Elephant Who Couldn't Eat Peanuts DVDs Help Children With Food Allergies 2Health News:New Alexander, the Elephant Who Couldn't Eat Peanuts DVDs Help Children With Food Allergies 3Health News:Chesapeake to Expand and Relocate North American Pharmaceutical Packaging Operation 2Health News:Scientists from Europe, Israel and the US develop robotic rats to aid in rescue missions 2Health News:Scientists from Europe, Israel and the US develop robotic rats to aid in rescue missions 3Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 2Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 3Health News:Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live 2Health News:Study finds patients with complex fibroadenomas can avoid surgery 2
(Date:8/3/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... reported financial results for the three months ended June ... accomplishments and upcoming milestones for its clinical development programs. ... very productive for CytRx. Enrollment in our ongoing pivotal ... tissue sarcoma (STS) continues on track to be completed ...
(Date:8/3/2015)... BioPharma Inc. (NASDAQ: ARRY ) today reported ... of its fiscal year ended June 30, 2015. ... noted, "Binimetinib and encorafenib, two innovative oncology products ... submissions in 2016. Additional data shared over the ... further validate the value of these programs by ...
(Date:8/3/2015)... , Aug. 3, 2015 Immune Pharmaceuticals, ... CEO, Dr. Daniel Teper , will present live ... August 6, 2015 TIME:   11:30AM EDT LINK:    ... live, interactive online event where investors are invited to ... the presentation hall as well as the association,s "virtual ...
Breaking Medicine Technology:CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
... NEW YORK, March 4, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental ... or "AOBO"), a pharmaceutical company dedicated to improving health ... range of prescription and over the counter ("OTC") products, ... and full year 2010 financial results on Monday, March ...
... Inc. (PRI) and AnswersMedia, LLC today announced the launch ... health, and nutrition information that enables consumers to make ... Advisor ( www.MPRPatientAdvisor.com ) integrates PRI,s ... healthcare practitioners for over 25 years as a leading ...
Cached Medicine Technology:American Oriental Bioengineering to Announce Fourth Quarter and Full Year 2010 Financial Results on March 14, 2011 2MPR Launches Patient Advisor—A Drug and Health Information Resource for Consumers From the Trusted Source Healthcare Practitioners Rely On 2
... Vitrectomy Lenses are a family of single-use direct ... of a particular region of the retinal surface ... less than 1 gram and is formed and ... of a human cornea. Lenses come in boxes ...
... The AFX Lens is a ... use in an air-filled eye. ... as a primary air-fluid exchange ... and sutureless design make it ...
... The Chalam 30° Prism are ... and are recommended for tractional ... and Rhegmatogenus retinal detachment. They ... photocoagulation and other midperipheral laser ...
... 45° Prism is designed ... and are recommended for ... BRVO etc.) and Rhegmatogenus ... be used for panretinal ...
Medicine Products: